Try For Free 7-Day Free Trial
Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.
|Overall||11 of 62|
|Sector (Life Science)||8 of 45|
|Type (IPO)||6 of 23|
|State (Colorado)||2 of 2|
|Country (United States)||11 of 59|
|Year (2003)||3 of 4|
San Diego, California, United States
Maxia Pharmaceutical, Inc. is a pharmaceutical company focused on small molecule drugs that target major diseases such as cancer and metabolic disorders.
Sunnyvale, California, United States
Oculex Pharmaceuticals, Inc. is an Ophthalmic drug delivery company.
Nexus Life Science Partners is a private equity firm that targets private and public healthcare companies located within the United States and around the world. The Firm's focus is on the growth segments of the healthcare industry. In particular, Nexus looks for product-driven life sciences companies developing breakthrough therapeutics for clinical needs, positively altering disease course and associated costs. The firm seeks for each private investment a potential for liquidity within 24 months after initial investment, as well as a 2-3 times return on invested capital. Nexus Life Science Partners was formed in 2001, and is based in New York, New York.
|Overall||1 of 22|
|Sector (Life Science)||1 of 18|
|Type (IPO)||1 of 6|
|State (Colorado)||1 of 1|
|Country (United States)||1 of 19|
|Year (2003)||1 of 1|
Calypso Medical Technologies
Seattle, Washington, United States
Calypso Medical Technologies, Inc. is a medical device company.
Cranbury, New Jersey, United States
Pharmacopeia, Inc. is a Drug Discovery identifying and developing small molecule drug candidates, with a primary focus on immunological diseases.